4//SEC Filing
Buell Jennifer 4
Accession 0000950170-24-005562
CIK 0001840229other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 8:00 PM ET
Size
7.9 KB
Accession
0000950170-24-005562
Insider Transaction Report
Form 4
Buell Jennifer
Chief Executive Officer
Transactions
- Award
Stock Option
2024-01-16+660,919→ 660,919 totalExercise: $0.87Exp: 2034-01-16→ Common Stock (660,919 underlying) - Award
Stock Option
2024-01-16+500,000→ 500,000 totalExercise: $0.87Exp: 2034-01-16→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]An option to purchase Common Stock was granted to Dr. Buell on January 16, 2024 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.
- [F2]An option to purchase Common Stock was granted to Dr. Buell on January 16, 2024 for her performance in 2023, and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Half of the options will vest on June 27, 2024 and half of the options will vest on September 27, 2024
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0001711184
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 8:00 PM ET
- Size
- 7.9 KB